To carry out its research activities, the Center has research support services and platforms
Resulting from the community involvement strategy of the CHAMPS (Child Health and Mortality Prevention and Surveillance) project, implemented by the Manhiça Health Research Center (CISM), a transport strategy will be implemented from 1 July in the district of Quelimane financed by CISM under the above-mentioned project. This strategy essentially aims to contribute to the transfer of bodies of children under 14 years old, from the Central Hospital of Quelimane (HCQ) to the community, thus hoping to reduce the rates of abandonment of bodies by some family members, due to financial difficulties.
CISM, in coordination with the Global Health Institute of Barcelona (ISGlobal), is implementing a project called 2G Color Plates that will test a new way of treating tuberculosis for two years in the Manhiça district. The proposed way is to use agar plates to diagnose phenotypic resistance to 11 anti-tuberculosis drugs, making it unique for this purpose.
The EARTH study (English acronym for: Early Anti-Retroviral Treatment in HIV) whose main objective is to monitor, from birth, the total level of Deoxyribonucleic Acid with Human Immunodeficiency Virus (DNA-HIV) and the virological and immunological characteristics of children treated early with antiretroviral drugs (aged ≤ 3 months), in order to identify participants with excellent virological and immunological control at 2 years of age, completed the recruitment process on May 1st, and are now starting the recruitment phase.
General Director
Administrative Director
Financial Director
TB & HIV Area Coordinator
(41.74% women and 58.26% men)
63 scientific publications
(2020)
22 Masters, 15 PhD and 4 Specialists
(20% Non-nationals)
